Assessment of pneumonia severity: A European perspective

European Respiratory Journal

Volumn 27, Issue 1, 2006, Pages 6-8

  Ewig, S ^a   Torres, A ^b   Woodhead, M ^c  

^a Augusta Kranken Anstalt   (Germany)

^b Institut Clínic Del Tòrax   (Spain)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; UREA;

BLOOD PRESSURE MEASUREMENT; BREATHING RATE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFIDENCE INTERVAL; CONFUSION; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; EUROPE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERCAPNIA; HYPOXEMIA; INTENSIVE CARE UNIT; LONG TERM CARE; LUNG INFILTRATE; LUNG VENTILATION PERFUSION RATIO; MORBIDITY; MORTALITY; PLEURA EFFUSION; PNEUMONIA SEVERITY INDEX; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS;

COMMUNITY-ACQUIRED INFECTIONS; EUROPE; HUMANS; PNEUMONIA; SEVERITY OF ILLNESS INDEX;

EID: 30744440695     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00130205     Document Type: Editorial

References (21)

1. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
2. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000; 31: 383-421.
3. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Infectious Diseases Society of America. Clin Infect Dis 2003; 37: 1405-1432.
4. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001; 56: Suppl. 4, IV1-64.
5. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180.
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
7. Ewig S, Kleinfeld T, Bauer T, Seifert K, Schäfer H, Göke N. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J 1999; 14: 370-375.
8. Roson B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001; 33: 158-165.
9. Ewig S, de Roux A, Garcia E, Mensa J, Niederman M, Torres A. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 2004; 59: 421-427.
10. Mortensen EM, Kapoor WN, Chang CCH, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37: 1617-1624.
11. British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 239: 195-220.
12. Karalus NC, Cursons RT, Leng RA, et al. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46: 413-418.
13. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community acquired pneumonia. Ann Intern Med 1991; 115: 428-436.
14. Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-1016.
15. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community-acquired pneumonia: a validation study. Thorax 2000; 55: 219-223.
16. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
17. Schaberg T, Gialdroni-Grassi G, Huchon G, Leophonte P, Manresa F, Woodhead M. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society. Thorax 1996; 51: 1017-1022.
18. Almirall J, Bolibar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15: 757-763.
19. Capelastegui A, Espana PP, Quintana JM, et al. Validation of a predictive rule for the managment of community-acquired pneumonia. Eur Respir J 2006; 27: 151-157.
20. Aujeski D, Auble TE, Yealy DM, et al. Prospective validation of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118: 384-392.
21. Angus DC, Marrie TJ, Obrosky S, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of the American and British Thoracic Society criteria. Am J Respir Crit Care Med 2002; 166: 717-723.